`
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`_____________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________________
`
`
`TEVA PHARMACEUTICALS USA, INC.,
`Petitioner
`
`v.
`
`CORCEPT THERAPEUTICS, INC.,
`Patent Owner
`_____________________
`
`CASE PGR2019-00048
`Patent 10,195,214
`_____________________
`
`
`TRANSMITTAL LETTER ACCOMPANYING
`SUBMISSION OF REPLACEMENT EXHIBIT 1056
`
`
`
`
`
`
`Mail Stop "PATENT BOARD"
`Patent Trial and Appeal Board
`U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`
`
`
`
`
`PGR2019-00048
`Patent No. 10,195,214 B2
`
`
`Petitioner Teva Pharmaceuticals USA, Inc. hereby submits replacement
`
`Exhibit 1056 (Korlym Label), in accordance with the Notice of Filing Date
`
`Accorded mailed on May 24, 2019. This replacement exhibit is identical to the
`
`document originally filed as Exhibit 1056 on May 7, 2019 but for the addition of
`
`the “TEVA1056” label.
`
`
`
` Respectfully submitted,
` STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.
`
`
`
`
`Date: May 28, 2019
`
`
`
` Deborah A. Sterling, Ph.D.
`Lead Attorney for Petitioner
`1100 New York Avenue, N.W. Registration No. 62,732
`Washington, D.C.20005-3934
`
`(202) 371-2600
`
`13240784.1
`
`
`
`
`- 1 -
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE (37 C.F.R. §§ 42.6(e))
`
`The undersigned hereby certifies that the above-captioned "Transmittal
`
`Letter Accompanying Submission of Exhibit 1056," along with replacement
`
`Exhibit 1056, was served in its entirety on May 28, 2019, via FedEx® at the
`
`correspondence address of record indicated in the Patent Office's public PAIR
`
`system for U.S. Patent No. 10,195,214 B2:
`
`
`
`KILPATRICK TOWNSEND & STOCKTON LLP/CORCEPT
`Mailstop: IP Docketing – 22
`1100 Peachtree Street
`Suite 2800
`Atlanta GA 30309
`
`
`
`Respectfully submitted,
`
`
`
`
`Date: May 28, 2019
`
`
` Deborah A. Sterling, Ph.D.
`Lead Attorney for Petitioner
`1100 New York Avenue, N.W. Registration No. 62,732
`Washington, D.C.20005-3934
`
`(202) 371-2600
`
`
`
`
`
`